ArticleCommunications medicine2026
Exploration of the genetic neuroinflammatory environment in the human midcingulate cortex in Huntington's disease.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundDespite progress, the pathophysiology involving neuroinflammation in Huntington's disease remains uncertain, and the genetic environment of the midcingulate cortex in the disease has not been investigated.
methodsUtilizing 14 Huntington's disease cases (6 females and 8 males; age range 41-72) split into mood, motor and mixed symptomatology and nine control cases (3 females and 6 males; age range 53-72), we used mRNA sequencing to examine the midcingulate cortex transcriptome in Huntington's disease and NanoString analysis to validate the differentially expressed transcripts. These genes underwent bioanalysis, including gene ontology enrichment, protein-protein interaction and cell-type enrichment analysis.
resultsHere we show that multiple neuroinflammatory transcripts are overexpressed in the Huntington's disease midcingulate cortex, such as those linked to classical complement, toll-like receptor signaling and AQP4 activity. However, related processes, such as chemokine activity, are downregulated, implying that a complex combination of gain and loss of neuroinflammatory function is occurring.
conclusionsIn summary, neuroinflammation-related transcripts are overrepresented in Huntington's disease cases with motor symptoms compared to mood and mixed. These findings suggest a potentially unique role for the midcingulate cortex in motor-specific neuroinflammatory pathophysiology.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.